AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04439526 — intervention group
Intervention type: DRUG
Intervention: Guselkumab
Description: Participants with moderate facial and/or genital psoriasis treated with guselkumab (as prescribed by their physician) in real world practice will be observed in this study.
Study NCT03314415 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Aldebaraan Nao H25
Description: The Aldebaraan Nao H25 is a humanoid robot with the capability to interact with people through small movements, gestures, and speech. It does not physically touch the participant at any time.
Study NCT03162224 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MEDI0457
Description: MEDI0457 7 mg will be administered intramuscularly followed by electroporation (EP) using CELLECTRA®5P device.
Study NCT03162224 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: CELLECTRA®5P device
Description: MEDI0457 7 mg will be administered intramuscularly followed by EP using CELLECTRA®5P device.
Study NCT03162224 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Durvalumab
Description: Durvalumab will be administered intravenously at a dose of 1500 mg every 4 weeks.
Study NCT02216175 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: SLIT to cow's milk
Description: Sublingual immunotherapy
Study NCT02216175 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Low dose OIT
Description: Oral Immunotherapy (low dose)
Study NCT02216175 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional OIT to cow's milk
Description: Oral Immunotherapy
Study NCT02216175 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Conventional OIT to cow's milk
Description: Oral Immunotherapy
Study NCT02216175 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Conventional OIT to cow's milk
Description: Oral Immunotherapy
Study NCT04480853 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fingolimod
Description: Fingolimod 0.5 mg QD, oral
Study NCT00676715 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo matching to ocrelizumab administered as IV infision in Cycle 1 Day 1.
Study NCT00676715 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ocrelizumab
Description: Ocrelizumab 300 mg was administered in cycle 1 followed by an infusion of ocrelizumab 600 mg on Day 1. A single infusion of ocrelizumab 600 mg was administered on Day 1 of cycles 3 and 4.
Study NCT00676715 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Avonex
Description: Avonex was administered weekly intramuscular injections of 30 mcg in cycle 1 Day 1.
Study NCT03905655 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Oral Tablet
Description: Number of placebo tablets administered orally depends on the arm
Study NCT03905655 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebo Oral Tablet
Description: Number of placebo tablets administered orally depends on the arm
Study NCT03905655 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Nitazoxanide
Description: Number of Nitazoxanide 300 mg extended release tablets administered orally depends on the arm
Study NCT03468426 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BI 836880
Description: intra-venous infusion
Study NCT03468426 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ezabenlimab
Description: intra-venous infusion
Study NCT02962687 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Care management via videoconference
Description: 12-week nurse care management for medically complex Veterans with CI delivered via videoconference
Study NCT02962687 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Care management via telephone calls
Description: 12-week nurse care management for medically complex Veterans with CI delivered via telephone calls
Study NCT01008033 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IDP-108
Description: Topical application once a day for 48 weeks
Study NCT01008033 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Vehicle
Description: Topical application once a day for 48 weeks
Study NCT03453398 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Shifts working hours with different schedules
Description: Workers in Group 1, 2, and 3 will undergo three different shift work modalities presenting different schedules.~Importantly, as an inclusion criteria, workers have to be involved in the same shift modality for at least one year at the time at the beginning of the study.
Study NCT03453398 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Shifts working hours with different schedules
Description: Workers in Group 1, 2, and 3 will undergo three different shift work modalities presenting different schedules.~Importantly, as an inclusion criteria, workers have to be involved in the same shift modality for at least one year at the time at the beginning of the study.
Study NCT00000392 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Peptide T
Study NCT00000392 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study NCT01796574 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Ketogenic diet
Description: 4:1 ratio fat: carbohydrates and protein ketogenic liquid via enteral feed
Study NCT03117738 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AstroStem
Description: Autologous adipose tissue derived mesenchymal stem cells (AdMSC)
Study NCT03117738 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo-Control
Description: Saline with 30% auto-serum
Study NCT01087853 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Crystalloid
Description: 2 litres intravenous infusion in 60 minutes
Study NCT01087853 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Colloid
Description: 1 litre intravenous infusion over 30 minutes
Study NCT03149887 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebo
Description: Inert solution created to appear as liposomal bupivacaine (Exparel) for injection
Study NCT03174470 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: TENS Stimulator
Description: Initial stimulation of arm (conditioning) followed by Increasing Intensities of Electrical Stimulation Delivered to The Bulbospongiosus Muscle
Study NCT01090349 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Implantation of an ICD/CRT-D device
Description: The Implantable Cardioverter Defibrillator (ICD) or Cardiac Resynchronization Therapy (CRT-D) device and leads are not the devices being evaluated in this investigation.
Study NCT01090349 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Implantation of an ICD/CRT-D device
Description: The Implantable Cardioverter Defibrillator (ICD) or Cardiac Resynchronization Therapy (CRT-D) device and leads are not the devices being evaluated in this investigation.
Study NCT01090349 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Merlin.NET PCN
Description: The Merlin.Net™ PCN is a dedicated computer system that connects physicians to patients outside of the clinic setting by centralizing data from remote transmissions, implant procedures and in-clinic follow-ups into single location with easy export to Electronic Health Record (EHR) systems
Study NCT01090349 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Merlin.NET PCN
Description: The Merlin.Net™ PCN is a dedicated computer system that connects physicians to patients outside of the clinic setting by centralizing data from remote transmissions, implant procedures and in-clinic follow-ups into single location with easy export to Electronic Health Record (EHR) systems
Study NCT01838564 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Routine Data collection
Description: Patients assigned to the control arm answered PediQUEST (PQ) surveys at most once a week and at least once a month. PQ-surveys were administered through a tablet computer if patient was at the clinic or ward or over the phone if patient was primarily at home. PQ-survey had 9 age- and respondent- adapted versions.~Control arm participants reported their satisfaction with the PediQUEST technology twice 4th and 8th PediQUEST administration. These surveys were embedded in PediQUEST.
Study NCT03494907 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Seltorexant
Description: Participants will be administered oral dose of seltorexant over-encapsulated tablets on Day 1.
Study NCT03494907 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo Matched to Seltorexant
Description: Participants will be administered matching placebo to seltorexant tablets on Day 1.
Study NCT01838564 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Routine Data collection
Description: Patients assigned to the control arm answered PediQUEST (PQ) surveys at most once a week and at least once a month. PQ-surveys were administered through a tablet computer if patient was at the clinic or ward or over the phone if patient was primarily at home. PQ-survey had 9 age- and respondent- adapted versions.~Control arm participants reported their satisfaction with the PediQUEST technology twice 4th and 8th PediQUEST administration. These surveys were embedded in PediQUEST.
Study NCT01838564 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Feedback of patient-reported outcomes
Description: Patients, parents and primary providers received printed reports summarizing patient/parent reported outcomes for last five visits. When child reported moderate-severe distress an email was automatically sent to primary providers (oncologist, nurses and psychosocial clinicians), as well as to the pain and palliative care services.
Study NCT02400554 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Yappalli
Description: Month 1-3: Up to 8 group sessions on Choctaw history, traditions, cultural systems, \& women's roles. Up to 3 individual Motivational Interviewing (MI) sessions to identify community leadership \& personal change goals on the main outcome.~Month 2: Overnight Culture Camp to strengthen group cohesion \& synthesize goals.~Month 3: Walk for a week on the Choctaw Trail of Tears, upon completion make a commitment to conduct a community-wide event based on personal \& leadership goals \& experience on the Trail.~Months 3-12: Up to 6 group meetings to plan community leadership events related to ATOD \& obesity prevention. Includes: digital storytelling training to create a story related to ATOD \& obesity prevention \& an individual MI booster session to revise their personal \& community leadership goals.~Month 12: Share digital stories \& community event experiences \& undergo a ceremony to transition to health leaders within their communities.
Study NCT00513045 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: IRT
Description: Cognitive behavior intervention
Study NCT00513045 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Exposure
Description: Exposure intervention
Study NCT04768413 — intervention group
Intervention type: OTHER
Intervention: Teleconsultation either by phone or by computer consultation. Quantitative and qualitative approaches to analysis
Description: A group of patients who have voluntarily adhered to the clinic's tele-assisted consultation and who receive remote, multidisciplinary team care without requiring physical displacement.
Study NCT04768413 — intervention group
Intervention type: OTHER
Intervention: Care modalities. Quantitative and qualitative approaches to analysis
Description: Group of patients who wish to continue with the usual face-to-face consultation, since for these patient's isolation measures allow trips to the care centers and who receive care from a multidisciplinary team on a regular basis.
Study NCT03314532 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: TILA-TACE
Description: After femoral artery catheterization, 5-Fr angiography catheters will be used for complete radiography of the celiac artery, the hepatic artery proper, left and right hepatic arteries and their branches, and 2.8-Fr micro-catheters will be used for complete radiography of the tumor's nutrient arteries. Lipiodol-epirubicin emulsions and 5% sodium bicarbonate injection solutions will be used for perfusion of chemotherapy drugs. Different sizes of embolic microspheres will be used alternatively for chemoembolization.
Study NCT04756973 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Behavioral weight loss program
Description: A 12 week small group weight loss program delivered via teleconference video technology
Study NCT04756973 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Behavioral weight loss program
Description: A 12 week small group weight loss program delivered via teleconference video technology
Study NCT03068195 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: microwave ablation
Description: KY2000 microwave ablation system was used in the experimental group. A power output of 60 W for 1-3 min for 1-3 cycles to treat the renal cysts according to the cysts size and classification.Percutaneous microwave ablation will be performed under the guidance of ultrasound while the laparoscopic microwave ablation will be performed under direct vision
Study NCT03068195 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: laparoscopic decortication
Description: conventional laparoscopic decortication will be performed to treat the renal cysts
Study NCT04793308 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Endodontic files
Description: Engine-driven nickel titanium Ni-Ti instruments
Study NCT04604392 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Rapid Maxillary Expansion Treatment
Description: The patients were treated with KBME, Hyrax and MIDME maxillary expansion appliances, respectively. All expansion appliances containing a Hyrax expansion screw positioned parallel to the second premolars and were used to correct the posterior crossbite. In the MIDME group, two mini-screws with a diameter of 1.6 mm and a length of 10 mm are located on the right and left sides between the roots of the 2nd premolar and 1st molar teeth with 60-70° angle. KBME and Hyrax expansion appliances were cemented with glass ionomer cement and MIDME was cemented with using the light-cured composite. Same protocol was applied to all patients during RME treatment. Expansion screws in all groups were activated by two turns a day.
Study NCT01614717 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: CRT-P Implant
Description: All patients will be implanted with a CRT-P device, then randomized to Treatment or Control Group
Study NCT01614717 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: CRT-P Implant
Description: All patients will be implanted with a CRT-P device, then randomized to Treatment or Control Group
Study NCT03755557 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Rhinocort
Description: Application of a nasal spray
Study NCT03755557 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Budesolv
Description: Application of a nasal spray
Study NCT03755557 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Application of a nasal spray
Study NCT01156623 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: EBUS-TBNA
Description: All included patients received TBNA for lymph node study via a flexible ultrasonic bronchoscope with a linear scanning probe on the tip (BF-UC206F-OL8, Olympus). The curved-probe scanned parallel to the insertion direction of bronchoscope, and the obtained images were linked to the ultrasound scanner (EU-2000C, Olympus) incorporated with Doppler-flow imaging. Each lymph node greater than 5mm in short axis measured by cursors was selected for subsequent TBNA with a 22-gauge (NA-201SX-4022, Olympus) needle in a condition of real-time EBUS guidance. A cytology examination was sent for pathologist blinded for the clinical history and image result of patients. When a tissue core was obtained by TBNA, the specimen was also sent for pathology study.
Study NCT01136356 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: buprenorphine
Description: parenteral buprenorphine may be administered at multiple times each day
Study NCT01136356 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: morphine
Description: parenteral morphine may be administered multiple times each day
Study NCT03334643 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Fiber mix
Description: Participants will test white bread or fiber mix over a span of 2 weeks. During each testing block, each food will be tested twice over two consecutive days. There are 4 testing blocks in total (one for white bread and three for fiber mix).
Study NCT03193372 — intervention group
Intervention type: DRUG
Intervention: Azelaic Acid (Finacea Foam, BAY39-6251)
Description: Finacea Foam, Active substance Azelaic acid
Study NCT02425124 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: PC101+Mental Health
Description: Facility-based stepped care intervention combining stress and depression case detection and management by non-physician clinicians and referral pathways for anti-depressant medication and/or group/individual counselling delivered by lay-health workers for patients with depression.
Study NCT02425124 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: PC101+Mental Health
Description: Facility-based stepped care intervention combining stress and depression case detection and management by non-physician clinicians and referral pathways for anti-depressant medication and/or group/individual counselling delivered by lay-health workers for patients with depression.
Study NCT04724083 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: biomarkers
Description: new diagnostic biomarkers
Study NCT00457002 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Apixaban
Description: Apixaban: Twice daily, 30 days~Placebo: Once daily, 6-14 days
Study NCT00457002 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Enoxaparin
Description: Enoxaparin: Once daily, 6-14 days~Placebo: Twice daily, 30 days
Study NCT03494907 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo Matched to Moxifloxacin
Description: Participants will be administered oral dose of moxifloxacin placebo tablet on Day 1.
Study NCT03494907 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Moxifloxacin Dose 1
Description: Participants will be administered oral dose 1 of moxifloxacin on Day 1.
Study NCT00759681 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ArterX Surgical Sealant
Description: Apply at the suture site.
Study NCT00759681 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Gelfoam and Thrombin
Description: Apply at the suture site.
Study NCT03667885 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Blood sample
Description: basic blood sample
Study NCT03667885 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: urine sample
Description: basic urine sample
Study NCT03667885 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Multi planar MRI
Description: T1 (with reduced affinity for fatty tissue) +/- contrast, diffusion weighted sequences and wash in/wash out
Study NCT01228890 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: CATCH-IT
Description: The CATCH-IT 2-R intervention has a motivational (3 PCP motivational interviews at time 0, 1.5 months and 12 months and 3 coaching phone calls at 2 and 4 weeks and 18 months) and an Internet component (with separate adolescent \[14 modules\] and parent \[5 modules\] programs). This revised and expanded intervention will include a comprehensive approach to reducing modifiable risk factors and enhancing resiliency factors associated with increased or decreased risk of depression, respectively, proposed by Spence and Reinecke.148 The revised CATCH-IT Tracker will monitor time in study and deploy elements of the intervention based on time since enrollment, including computer and human elements (e.g. calls, doctor visits).
Study NCT01228890 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: AMPE
Description: The AMPE components are similar to those employed in previous primary care based quality improvement/Chronic Care Model Interventions (patient education \[psycho-education described below\], provider training \[described in Case Finding and Recruitment\], active monitoring and referral \[case management, discussed under assessments\], physician and nurse education and routine contact with PCP \[study design rationale\]). This Internet site will focus on assisting parents and adolescents in early identification of need for treatment and will also target stigma and negative attitudes toward treatment of mental disorders we have previously identified as barriers to seeking and adhering to treatment.
Study NCT02531477 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: propofol
Description: intracarotid propofol as an anesthetic agent
Study NCT03805568 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: dexmedetomidine infusion group
Description: dexmedetomidine as anaesthetic adjuvant
Study NCT03805568 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: remifentanil infusion group
Description: remifentanil as anaesthetic adjuvant
Study NCT01483963 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: AA4500 0.29 mg/1 mL
Description: treatment of adhesive capsulitis
Study NCT01483963 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: AA4500 0.58 mg/2 mL
Description: treatment of adhesive capsulitis
Study NCT01483963 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: AA4500 0.58 mg/1 mL
Description: treatment of adhesive capsulitis
Study NCT01483963 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: AA4500 0.58 mg/0.5 mL
Description: treatment of adhesive capsulitis